E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/26/2007 in the Prospect News Special Situations Daily.

Millenco reports 5.5% stake in Aradigm

By Lisa Kerner

Charlotte, N.C., Nov. 26 - Investors led by Millenco LLC bought 699,355 shares of Aradigm Corp. stock priced from $1.55 to $1.96 to each.

The shares were purchased between Nov. 1 and Nov. 20, according to a schedule 13D filing with the Securities and Exchange Commission.

Millenco owns 2,946,148 shares or some 5.5% of the Hayward, Calif., company. Aradigm develops non-invasive delivery systems for self-administration of biopharmaceuticals and small molecules.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.